Screening Method for Active Agents for the Prophylaxis and Therapy of Neurodegenerative Diseases

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent describes a method for screening active compounds that can prevent or treat neurodegenerative diseases, especially Alzheimer's disease. The screening is based on the ability of substances to inhibit the transport of the toxic peptide Aß42 into cells, particularly into the cell nucleus. The patent also covers diagnostic and therapeutic applications that rely on detecting, modulating, or blocking the cellular uptake and gene-regulatory effects of Aß42.

Use CasesContent extracted from patent full text and abstract with AI.

• Pharmaceutical drug development for Alzheimer's disease and other neurodegenerative conditions by identifying new drug candidates that block Aß42 entry into cells.
• Screening of compound libraries for potential neuroprotective drugs.
• Diagnostic tests for assessing the risk or presence of neurodegenerative diseases by measuring Aß42 accumulation in cell nuclei.
• Research tools for understanding the molecular mechanisms of neurodegeneration and gene regulation by Aß42.
• Development of personalized medicine strategies by targeting individual gene regulatory pathways linked to Aß42 activity.

BenefitsContent extracted from patent full text and abstract with AI.

• Enables more targeted and efficient discovery of drugs that may slow or prevent progression of Alzheimer's and related diseases.
• Offers a novel mechanism of action (blocking Aß42 nuclear transport and gene regulation), potentially leading to more effective therapies compared to existing treatments.
• Facilitates early diagnosis or risk assessment for neurodegenerative diseases by providing new biomarkers (nuclear Aß42 accumulation).
• Can be used to develop both therapeutic and diagnostic products, broadening its commercial and clinical impact.
• Allows for high-throughput screening and adaptation to various cell types, making it suitable for widespread adoption in pharmaceutical research.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

A screening method for active substances used for preventing and treating neurodegenerative diseases, preferably Alzheimer's disease, is described, said active substances inhibiting Aß42 transport into the cell, preferably the cell core. Diagnostic and therapeutic applications based on said method are also described.